References
- Carbone S, Lavie CJ. An opposing point of view on the obesity paradox. Postgrad Med. 2019 Jun;131(5):333–334.
- Chrysant SG, Chrysant GS. The single use of body mass index for the obesity paradox is misleading and should be used in conjunction with other obesity indices. Postgrad Med. 2019;131(2):96–102.
- Flegal KM, Kit BK, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories. A systematic review and meta-analysis. JAMA. 2013;309:71–82.
- Bell JA, Kivimaki M, Hamer M. Metbolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obesity Rev. 2014;15:504–515.
- Caleyachetty R, Thomas GN, Toulis KA, et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol. 2017;70:1429–1437.
- Flegal KM, Ioanidis JP. The obesity paradox: a misleading term that should be abandoned. Obesity. 2018;26:629–630.
- Peeters A. Journals should no longer accept “obesity paradox” articles. Int J Obes. 2018;42(3):584–585.
- Pandey A, Patel KV, Lavie CJ. Obesity, central adipocity, and fitness: understanding the obesity paradox in the context of other cardiometabolic parameters. Mayo Clin Proc. 2018;93(3):676–678.
- Lacie CJ, Cahalin LP, Chase P. et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc. 2013;88(3):251–258.
- McAuley PA, Keteyian SJ, Brawner CA. et al. Exercise capacity and the obesity paradox in heart failure: the FIT project. Mayo Cin Proc. 2018;93(6):701–708.
- Yamashita M, Kamiya K, Matsunaga A, et al. Prognostic value of sarcopenic obesity estimated by computed tomography in patients with cardiovascular disease and undergoing surgery. J Cardiol. 2019 March 27. DOI:10.1016/J.JJcc 2019.02.010
- Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA. 2018;3(4):280–287.